Ianalumab, Corticosteroids — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-29 in 4mo
ESTIMATED |
READOUT
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in P
Phase 3 · Primary Immune Thrombocytopenia (ITP) |
NVS NOVARTIS AG | Ianalumab, Corticosteroids |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|